CN101489985A - 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 - Google Patents
具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 Download PDFInfo
- Publication number
- CN101489985A CN101489985A CNA200680055379XA CN200680055379A CN101489985A CN 101489985 A CN101489985 A CN 101489985A CN A200680055379X A CNA200680055379X A CN A200680055379XA CN 200680055379 A CN200680055379 A CN 200680055379A CN 101489985 A CN101489985 A CN 101489985A
- Authority
- CN
- China
- Prior art keywords
- ibuprofen
- structural formula
- general formula
- carbon atom
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/62—Quaternary ammonium compounds
- C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | A | B1 | B2 | C1 | C2 | D1 | D2 |
剂量(mg/kg) | 0 | 50 | 100 | 50 | 100 | 50 | 100 |
扭体次数 | 34.2 | 17.2 | 13.1 | 14.1 | 10.2 | 13.3 | 9.8 |
% | - | 50 | 62 | 59 | 70 | 61 | 71 |
组别 | t=0min. | t=90min. | t=180min. | t=270min. |
对照组(A) | 37.35±0.05 | 37.25±0.07 | 37.33±0.05 | 37.32±0.08 |
布洛芬(B1,口服100mg/kg) | 37.25±0.06 | 36.83±0.05 | 36.80±0.08 | 36.78±0.07 |
布洛芬(B2,口服150mg/kg,) | 37.35±0.09 | 36.59±0.07 | 36.53±0.06 | 36.55±0.05 |
布洛芬前药(C1,口服100mg/kg) | 37.22±0.07 | 36.40±0.06 | 36.50±0.05 | 36.45±0.08 |
布洛芬前药(C2,口服150mg/kg) | 37.24±0.08 | 36.30±0.05 | 36.35±0.07 | 36.38±0.08 |
布洛芬前药(D1,透皮给药100mg/kg) | 37.27±0.06 | 36.30±0.06 | 36.35±0.08 | 36.31±0.07 |
布洛芬前药(D2,透皮给药150mg/kg) | 37.26±0.05 | 36.25±0.05 | 36.30±0.07 | 36.20±0.05 |
Claims (9)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2006/052461 WO2008010025A1 (en) | 2006-07-18 | 2006-07-18 | Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310738823.XA Division CN103948571A (zh) | 2006-07-18 | 2006-07-18 | 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101489985A true CN101489985A (zh) | 2009-07-22 |
CN101489985B CN101489985B (zh) | 2014-01-08 |
Family
ID=38956590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200680055379.XA Active CN101489985B (zh) | 2006-07-18 | 2006-07-18 | 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP3210964A1 (zh) |
JP (1) | JP5144658B2 (zh) |
CN (1) | CN101489985B (zh) |
AU (1) | AU2006346288A1 (zh) |
CA (1) | CA2657636C (zh) |
DK (1) | DK2041068T3 (zh) |
ES (1) | ES2616315T3 (zh) |
HK (1) | HK1135958A1 (zh) |
HU (1) | HUE033687T2 (zh) |
PL (1) | PL2041068T3 (zh) |
PT (1) | PT2041068T (zh) |
WO (1) | WO2008010025A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101687792A (zh) * | 2007-06-04 | 2010-03-31 | 于崇曦 | 具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其新的医药用途 |
CN109432061A (zh) * | 2018-11-09 | 2019-03-08 | 北京德默高科医药技术有限公司 | 含有布洛芬或其结构类似物的多层经皮给药*** |
WO2019080693A1 (zh) | 2017-10-26 | 2019-05-02 | 浙江越甲药业有限公司 | 一种稳定的含有非甾体抗炎药衍生物的药物组合物 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
JP5378219B2 (ja) | 2006-10-02 | 2013-12-25 | テックフィールズ バイオケム カンパニー リミテッド | 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ |
JP5424887B2 (ja) | 2006-11-08 | 2014-02-26 | チョンシー ユー | ペプチド及び関連化合物の経皮送達システム |
CA2671938C (en) | 2006-12-10 | 2017-10-17 | Chongxi Yu | Transdermal delivery systems of beta-lactam antibiotics |
CN101605754B (zh) | 2007-01-15 | 2015-09-16 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的维生素a酸类和类维生素a酸化合物的前药 |
ES2607901T3 (es) | 2007-01-31 | 2017-04-04 | Chongxi Yu | Profármacos hidrosolubles cargados positivamente de 1H-imidazo[4,5-c]quinolin-4-aminas y compuestos relacionados con ratas de penetración de piel muy altas |
WO2008110351A2 (en) * | 2007-03-15 | 2008-09-18 | Dompe' Pha.R.Ma S.P.A. | Use of (r) and (s)-2-aryl-propionic acid derivatives as antiseptic agents |
KR20210123406A (ko) * | 2008-12-04 | 2021-10-13 | 충시 위 | 고투과력을 가진 조성물 및 이의 적용 |
EP2408443A1 (en) * | 2009-03-16 | 2012-01-25 | Genmedica Therapeutics SL | Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
ES2845612T3 (es) | 2009-05-08 | 2021-07-27 | Techfields Biochem Co Ltd | Composiciones de profármaco de alta penetración de péptidos y compuestos relacionados con péptidos |
US9969751B2 (en) | 2009-06-10 | 2018-05-15 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
CN109608436B (zh) * | 2011-04-08 | 2022-10-11 | 斯法尔制药私人有限公司 | 取代的甲基甲酰基试剂及使用所述试剂改进化合物物理化学和/或药代动力学性质的方法 |
PL2849738T3 (pl) | 2012-01-18 | 2024-05-13 | Techfields Pharma Co., Ltd. | Kompozycje proleków o dużej szybkości przenikania i ich kompozycje farmaceutyczne do leczenia chorób płuc |
CA2917145C (en) | 2013-03-15 | 2023-10-24 | Techfields Pharma Co., Ltd. | Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases |
US9862698B2 (en) | 2014-12-16 | 2018-01-09 | Adt Pharmaceuticals, Inc. | Indenyl compounds, pharmaceutical compositions, and medical uses thereof |
US20160168108A1 (en) | 2014-12-16 | 2016-06-16 | Adt Pharmaceuticals, Inc. | Method of treating or preventing ras-mediated diseases |
JP6153264B2 (ja) * | 2015-01-05 | 2017-06-28 | テックフィールズ インコーポレイテッド | 非常に速い皮膚及び膜浸透速度を有するnsaiaプロドラッグ及びその新規医薬使用 |
EP3784228A1 (en) | 2018-04-26 | 2021-03-03 | ADT Pharmaceuticals, LLC | Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses |
EP4021427A4 (en) * | 2019-08-30 | 2023-09-20 | Remedy Diagnostics LLC | TRANSDERMAL DEVICE COMPRISING PAIN MOLECULES |
IL302978A (en) * | 2020-06-05 | 2023-07-01 | Techfields Inc | Local administration of 2-(diethylamino)ethyl 2-(4-isobutylphenyl)propionate for the treatment of diseases |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0284612B1 (en) | 1986-01-30 | 1991-07-24 | University of Utah | Treatment of bone loss |
IT1208736B (it) * | 1986-03-04 | 1989-07-10 | Sigma Tau Ind Farmaceuti | Alogenuri dell'estere del 2-n,n,n,dimetil-alchil-amminoetanolo con acido acetico variamente sostituito e composizioni farmaceutiche che licontengono ad attivita' antiinfiammatoria e antisettica |
JPS6452742A (en) * | 1987-04-27 | 1989-02-28 | Syntex Pharma Int | Omega-quaternary ammonium alkyl ester and thioester of acidic non-steroidal antiinflammatory |
US5100918A (en) | 1989-05-25 | 1992-03-31 | Sterling Drug, Inc. | Prevention or treatment of sunburn using the S(+) isomer of ibuprofen |
AUPN531195A0 (en) | 1995-09-11 | 1995-10-05 | J.W. Broadbent Nominees Pty. Ltd. | Lipid extract having anti-inflamatory activity |
DE19716713A1 (de) * | 1997-04-21 | 1998-10-22 | Paz Arzneimittelentwicklung | Arzneimittel, enthaltend Ibuprofenthioester als Hemmer der Nf-kappaB abhängigen Bildung von Mediatoren von Entzündung und Schmerz |
US5885597A (en) | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
MXPA00012844A (es) | 1998-07-07 | 2004-05-21 | Transdermal Technologies Inc | Composiciones para la liberacion transdermica rapida y sin irritacion de agentes farmaceuticamente activos y metodos para formular tales composiciones y liberar los mismos. |
US6645520B2 (en) * | 1999-12-16 | 2003-11-11 | Dermatrends, Inc. | Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
US6416772B1 (en) | 2001-01-12 | 2002-07-09 | H. Wayne Van Engelen | Topical dermal anaesthetic |
US6528040B1 (en) | 2001-01-18 | 2003-03-04 | Maurine Pearson | EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic |
ITMI20010395A1 (it) * | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
WO2002085297A2 (en) * | 2001-04-24 | 2002-10-31 | East Carolina University | Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease |
ITMI20012025A1 (it) * | 2001-09-28 | 2003-03-28 | Dompe Spa | Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono |
US7052715B2 (en) | 2003-04-11 | 2006-05-30 | All Natural Fmg, Inc. | Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
JP5759672B2 (ja) * | 2006-07-09 | 2015-08-05 | テックフィールズ バイオケム カンパニー リミテッド | アスピリンの正荷電水溶性プロドラッグ |
EP2756843A3 (en) * | 2006-07-25 | 2014-08-20 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate |
AU2006347391B2 (en) * | 2006-08-15 | 2013-03-07 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
-
2006
- 2006-07-18 PT PT67801266T patent/PT2041068T/pt unknown
- 2006-07-18 CA CA2657636A patent/CA2657636C/en active Active
- 2006-07-18 JP JP2009520065A patent/JP5144658B2/ja not_active Expired - Fee Related
- 2006-07-18 DK DK06780126.6T patent/DK2041068T3/en active
- 2006-07-18 ES ES06780126.6T patent/ES2616315T3/es active Active
- 2006-07-18 HU HUE06780126A patent/HUE033687T2/en unknown
- 2006-07-18 CN CN200680055379.XA patent/CN101489985B/zh active Active
- 2006-07-18 PL PL06780126T patent/PL2041068T3/pl unknown
- 2006-07-18 EP EP17152505.8A patent/EP3210964A1/en not_active Withdrawn
- 2006-07-18 WO PCT/IB2006/052461 patent/WO2008010025A1/en active Application Filing
- 2006-07-18 AU AU2006346288A patent/AU2006346288A1/en not_active Abandoned
- 2006-07-18 EP EP06780126.6A patent/EP2041068B1/en not_active Not-in-force
-
2010
- 2010-01-11 HK HK10100235.3A patent/HK1135958A1/zh unknown
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101687792A (zh) * | 2007-06-04 | 2010-03-31 | 于崇曦 | 具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其新的医药用途 |
CN101687792B (zh) * | 2007-06-04 | 2016-03-02 | 于崇曦 | 具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其医药用途 |
WO2019080693A1 (zh) | 2017-10-26 | 2019-05-02 | 浙江越甲药业有限公司 | 一种稳定的含有非甾体抗炎药衍生物的药物组合物 |
CN111565708A (zh) * | 2017-10-26 | 2020-08-21 | 浙江越甲药业有限公司 | 一种稳定的含有非甾体抗炎药衍生物的药物组合物 |
CN111565708B (zh) * | 2017-10-26 | 2023-07-25 | 浙江越甲药业有限公司 | 一种稳定的含有非甾体抗炎药衍生物的药物组合物 |
US11986453B2 (en) | 2017-10-26 | 2024-05-21 | Zhejiang Yuejia Pharmaceuticals Co., Ltd | Stable pharmaceutical composition containing non-steroidal anti-inflammatory drug derivative |
CN109432061A (zh) * | 2018-11-09 | 2019-03-08 | 北京德默高科医药技术有限公司 | 含有布洛芬或其结构类似物的多层经皮给药*** |
Also Published As
Publication number | Publication date |
---|---|
ES2616315T3 (es) | 2017-06-12 |
HUE033687T2 (en) | 2017-12-28 |
EP2041068A1 (en) | 2009-04-01 |
WO2008010025A1 (en) | 2008-01-24 |
JP2009543857A (ja) | 2009-12-10 |
JP5144658B2 (ja) | 2013-02-13 |
HK1135958A1 (zh) | 2010-06-18 |
CA2657636C (en) | 2021-11-09 |
AU2006346288A1 (en) | 2008-01-24 |
PL2041068T3 (pl) | 2017-05-31 |
PT2041068T (pt) | 2017-02-17 |
EP2041068A4 (en) | 2010-09-29 |
EP2041068B1 (en) | 2017-01-25 |
DK2041068T3 (en) | 2017-02-27 |
EP3210964A1 (en) | 2017-08-30 |
CA2657636A1 (en) | 2008-01-24 |
CN101489985B (zh) | 2014-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101489985B (zh) | 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 | |
CN101506168B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 | |
CN101506161B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药 | |
JP5466006B2 (ja) | 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ | |
CN101484415B (zh) | 带有正电荷的水溶性阿司匹林前药 | |
CN101500983A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药 | |
EP2046727B1 (en) | Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate | |
CN101506160A (zh) | 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药 | |
CN101500984A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 | |
AU2013231152B2 (en) | Positively charged water-soluble pro-drugs of ibuprofen | |
CN104622858B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 | |
CN104610077B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 | |
CN103948571A (zh) | 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 | |
CN105439877B (zh) | 带正电荷的水溶性二氟尼柳及相关化合物的前药 | |
CN104974058A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性双氯芬酸前药 | |
CN104706630B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 | |
AU2006347925B2 (en) | Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate | |
AU2018202140A1 (en) | Positively charged water-soluble pro-drugs of ibuprofen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1135958 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: TECHFIELDS BIOCHEMICAL TECHNOLOGY CO., LTD. Effective date: 20131204 Owner name: TIANJIN XINCHEN TAIFEIER MEDICAL TECHNOLOGY CO., L Free format text: FORMER OWNER: YU CHONGXI Effective date: 20131204 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; TO: 300457 HANGU, TIANJIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131204 Address after: 300457, Tianjin economic and Technological Development Zone, Huang Hai Road, No. 276 TEDA SME Park, building 4, House No. 103 Applicant after: TIANJIN XINCHEN TAIFEIER PHARMACEUTICAL TECHNOLOGY CO., LTD. Address before: Illinois State Applicant before: Yu Chongxi Applicant before: Shanghai Techfields Biochemical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1135958 Country of ref document: HK |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210812 Address after: 226400 No. 9, Jingye Road, juegang street, Rudong County, Nantong City, Jiangsu Province Patentee after: Jiangsu Xinchen taifeier Pharmaceutical Technology Co.,Ltd. Address before: Room 103, building 4, TEDA SME Park, 276 Huanghai Road, Tianjin Economic and Technological Development Zone, 300457 Patentee before: Techfields Biochem Co.,Ltd. |